Curious how many lives were truly improved by adjuvant CDK4/6 inhibitors?
When >$300K buys toxicity, not survival, we need to ask harder questions.
Are we treating cancer—or trial endpoints? 🤔
#DeSci #CDK46
https://ascopubs.org/doi/full/10.1200/JCO-24-02683?bid=481876439&md5=7e79303c6661e4474f78c7f440999a06&cid=DM20245
Post #53
19.4K
Journal of Clinical Oncology Why We Do Not Recommend That Women With Breast Cancer Receive Adjuvant Treatment With a CDK4/6 Inhibitor
- 👍 944
- ❤ 734
- 🤝 702
- 🔥 533
- 🤩 429
- 🎉 318
- 👏 136
- 🥰 119